Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial.
文献类型：期刊论文
| 作者 | Guo, Weijian; Zhu, Xiaodong; Huang, Mingzhu; Wang, Yusheng; Chen, Zhiyu; Feng, Wanjing; He, Yifu; Zhang, Xiaowei; Liu, Xin; Wang, Chenchen |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2021-05-20 |
| 卷号 | 39 |
| ISSN号 | 0732-183X |
| DOI | 10.1200/JCO.2021.39.15_suppl.4014 |
| 资助项目 | National Key Research and Development Program of China[2017YFC1308900] |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| WOS记录号 | WOS:000708120602116 |
| 资助机构 | National Key Research and Development Program of China |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/126498]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China 2.Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China 3.Shanxi Tumor Hosp, Taiyuan, Peoples R China 4.Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China 5.USTC West Dist & Anhui Prov Canc Hosp, Dept Oncol, Affiliated Hosp 1, Hefei, Peoples R China 6.China Med Univ, Canc Hosp, Liaoning Canc Hosp & Inst, Shenyang, Peoples R China 7.Chinese Acad Sci, Canc Hosp, Univ Chinese Acad Sci, Zhejiang Canc Hosp,Inst Canc & Basic Med IBMC, Hangzhou, Zhejiang, Peoples R China 8.Soochow Univ, Dept Oncol, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China 9.Nantong Tumor Hosp, Nantong, Peoples R China 10.Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China |
| 推荐引用方式 GB/T 7714 | Guo, Weijian,Zhu, Xiaodong,Huang, Mingzhu,et al. Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39. |
| APA | Guo, Weijian.,Zhu, Xiaodong.,Huang, Mingzhu.,Wang, Yusheng.,Chen, Zhiyu.,...&Wang, XiaoFeng.(2021).Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial..JOURNAL OF CLINICAL ONCOLOGY,39. |
| MLA | Guo, Weijian,et al."Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial.".JOURNAL OF CLINICAL ONCOLOGY 39(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。